See how Nancy Pelosi actually votes — against your values.
DeepSyte scores Nancy Pelosi's record on the issues you care about — not party, not press releases. Take the 2-minute values quiz to see your personal alignment.
Sign in and take the values quiz to see how Nancy Pelosi's votes line up with your views.
Prediction track record
How often we called Nancy Pelosi's passage votes correctly, from their stated positions on each bill's tagged topics. Excludes “unclear” calls and abstentions.
2 predictions on record · none have been resolved by a passage vote yet. Check back as bills move.
No paired statements and votes yet for Nancy Pelosi
We haven't yet found statement/vote pairs on the same topic for Nancy Pelosi. This usually means either the rep hasn't taken public positions on bills that have come to a passage vote, or those bills haven't been tagged yet. The checker runs as new press releases and votes come in.
Pro analysis
AI rep analysis — Pro
Get an AI-narrated read on Nancy Pelosi's full voting record against your stated values — aligned themes, conflicts, notable votes, and what to watch for.
We haven't extracted campaign positions for Nancy Pelosi yet. Once their campaign website or position pages are processed, this card will track what they said vs how they voted.
Crossing the aisle
Passage votes where Nancy Pelosi broke ranks with ≥75% of Democrats. Threshold catches substantively partisan splits; unanimous-ish or close votes are excluded.
Pelosi Statement on Eight Years Since the Iran Nuclear Agreement Withdrawal
Position: Speaker Emerita Pelosi argues that President Trump's withdrawal from the Iran Nuclear Agreement was a strategic error that destabilized the region and increased conflict, and that serious diplomacy rather than military action is necessary to address Iran's nuclear and terrorism concerns.
San Francisco – Speaker Emerita Nancy Pelosi issued the following statement marking eight years since President Trump withdrew from the Iran Nuclear Agreement:
“Eight years ago, Donald Trump followed through on a misguided and uninformed campaign promise by recklessly ripping up the Joint Comprehensive Plan of Action—a landmark multilateral diplomatic agreement masterfully negotiated by President Obama that successfully strengthened global security and verifiably prevented Iran from obtaining a nuclear weapon.
"Eight years after destroying that working agreement, Donald Trump has cost American lives by engulfing the region in the very conflict that serious diplomacy was meant to prevent. Even now, the President seeks concessions to end his war of choice that would leave the world less secure than under the very deal he dismantled.”
"Democrats have never had any illusions about the Iranian regime. We remain firmly committed to countering Iran’s support for terrorism, confronting its ballistic missile program and preventing it from obtaining a nuclear weapon. But the President’s reckless decisions are no substitute for serious statecraft.”
Pelosi Joins Over 250 Congressional Democrats To Protect Mifepristone Access
Position: Congressional Democrats filed an amicus brief with the Supreme Court opposing a Fifth Circuit decision that would restrict mifepristone access by reimposing an in-person dispensing requirement. The lawmakers argue that mifepristone has been repeatedly affirmed as safe by the FDA, that the court decision undermines the FDA's evidence-based approval process, and that restricting access exacerbates reproductive health care access disparities.
Washington, D.C. – Yesterday, Speaker Emerita Nancy Pelosi joined more than 250 Senate and House Democrats—led by Senate Democratic Leader Chuck Schumer (D-NY); Senators Patty Murray (D-WA), Dick Durbin (D-IL), and Ron Wyden (D-OR); House Democratic Leader Hakeem Jeffries (D-NY); and Representatives Katherine Clark (D-MA), Frank Pallone Jr. (D-NJ), Diana DeGette (D-CO), Jamie Raskin (D-MD), and Ayanna Pressley (D-MA)—in filing an amicus brief to the Supreme Court urging them to overturn a Fifth Circuit decision that would upend the FDA approval process and restrict access to mifepristone. This brief follows emergency appeals from the manufacturers of mifepristone; the Supreme Court issuing a temporary stay of the decision Monday morning until next Monday, May 11; and the announcement that the Court has ordered briefing on the stay by this Thursday, May 7.
The lawmakers argued that mifepristone already undergoes a rigorous FDA approval process, and the medication has repeatedly been found to be safe and effective. For a court to overturn this decision not only limits who is able to receive this vital and life-saving medication, putting lives at risk, but it also undermines the longstanding, congressionally mandated, and evidence-based decision-making process at the FDA.
“For more than a quarter century, FDA has repeatedly and consistently affirmed that mifepristone is safe. Over seven million patients in the U.S. have safely used mifepristone. And as with other drugs, FDA continues to monitor the post-marketing safety data on mifepristone—data confirming that mifepristone is safe without regard to how it is dispensed,” the members wrote.
The lawmakers also argued that the Fifth Circuit ruling was clearly not based on the merits of the distribution method of mifepristone, or the scientific backing of the medication, but rather a desire to limit the ability of individuals to receive abortion medication. The emergency stay is necessary to ensure that Louisiana is not able to deny medically appropriate care to patients far beyond the state’s borders.
“Decades after FDA’s initial approval of mifepristone and years after the in-person dispensing requirement was eliminated, the Fifth Circuit on an ‘emergency’ basis ordered FDA to re-impose this onerous nationwide restriction on all Americans. Allowing that decision to remain in place undermines the science-based statutory framework Congress commands and threatens patient access to reproductive health care,” the members continued. “As has been well publicized, many U.S. residents in states where abortion is legal live far from any reproductive health care provider. Reinstating an in-person dispensing requirement for mifepristone exacerbates an already significant reproductive health crisis by limiting access to the most common method of early abortion.”
The members argued that this is a clear case of judicial overreach by a lower district court.
“Preserving evidence-based access to mifepristone, including when dispensed by mail or retail pharmacy, is necessary to mitigate the imminent harm facing members of the public. Women deserve access to mifepristone for reproductive health care, and all Americans deserve integrity in the congressionally mandated, evidence-based process for FDA’s drug regulatory decisions,” the members concluded.
In the Senate, the amicus brief was signed by all 47 Democratic U.S. Senators.
In the House, the brief was signed by 212 Democratic U.S. Representatives.
The lawmakers’ amicus brief to the Supreme Court can be read in full HERE.
Pelosi Statement on Supreme Court Ruling to Weaken Fair Representation
Position: Pelosi opposes the Supreme Court's ruling in Louisiana v. Callais, which she characterizes as weakening the Voting Rights Act, and calls for Congress to pass the John R. Lewis Voting Rights Advancement Act to restore voting protections.
Washington D.C. – Speaker Emerita Nancy Pelosi issued the following statement on the Supreme Court's ruling in Louisiana v. Callais:
“Today, the Supreme Court has dealt a devastating new blow to the Voting Rights Act and against the sacred right to vote.
"The consequences will be felt across the country: fewer voices heard, fewer communities represented and a democracy diminished.
"Congress must urgently pass the John R. Lewis Voting Rights Advancement Act to restore the full strength of the Voting Rights Act before this latest blow becomes fatal.”
Pelosi, House Democrats Slam Republican Rewrite of Women’s History Museum Bill, Demand Restoration of Latino Museum
Position: House Democrats oppose the Republican-amended version of the Smithsonian American Women's History Museum Act, demanding restoration of the bipartisan bill language and insisting that passage be paired with the National Museum of the American Latino Act. They object to provisions giving the President control over museum design and location, and to language restricting inclusion to 'biological women,' which they argue threatens transgender women and girls.
Washington D.C. – Yesterday, Speaker Emerita Nancy Pelosi joined 145 Members of the House Democratic Caucus in sending a letter to Speaker Mike Johnson urging him to restore the longstanding, bipartisan version of H.R. 1329, the Smithsonian American Women’s History Museum Act, which would solidify plans for the museum. In their letter, Members make clear their support for passage of the bill depends on Republicans reinstating the bill’s bipartisan foundation and commitment to pair it with H.R. 1330, the Smithsonian National Museum of the American Latino Act.
This letter follows a March 18 House Administration Committee hearing in which House Republicans introduced and adopted a hyperpartisan version of the bill that abruptly derailed the years-long, bipartisan effort to advance the Smithsonian American Women’s History Museum and National Museum of the American Latino. The bill as reported out of Committee gives unprecedented and undue control over the museum to President Trump. It also threatens the inclusion of transgender women and girls from the museum while opening the door to broader exclusion of other women. Before this last minute amendment, the work to establish the Smithsonian American Women’s History Museum had been a bipartisan effort rooted in the joint conviction that women’s history and women’s stories are central to the identity of our nation.
In the letter, the Members emphasized that the design and location of a museum about women, fought for and supported by women, should not be controlled by one man.
“The buildings that house museums are interpretative objects themselves. Their design and location frame how visitors understand the content inside. The design and location of a museum about women, fought for and supported by women, should not be controlled by one man and his loyalists—particularly not a man who has been found liable for sexual assault, and regularly denigrates women based on physical appearance, among other repulsive behaviors. American women deserve better. The American people deserve better.”
The Members also explain that a provision in the Republican-amended version threatens the inclusion of transgender women and girls while opening the door to broader exclusion of other women.
“The amended bill also now vaguely states that only ‘biological women’ can be included in the museum. While the author’s intent is clearly to target transgender women and girls, the provision invites arbitrary enforcement and could be used to challenge the inclusion of any woman or girl a politician deems not ‘feminine’ enough. This is just another example of Republicans needlessly adding an anti-transgender provision to an unrelated bill that would impact not just transgender women and girls but all women and girls.”
The Members close by declaring that their support for the Smithsonian American Women’s History Museum bill is contingent on the retention of the museum’s spirit and the bill’s bipartisan foundation.
“If Republicans truly want to celebrate women’s history, we call on you and your colleagues to restore the bipartisan version of this bill and move it forward with us. Our support for this bill is contingent on the retention of the museum’s spirit and the bill’s bipartisan foundation. Absent those conditions, we will be compelled to oppose the politicized version of H.R. 1329 on the House floor.”
Read the letter here.
Pelosi Floor Speech on Iran War Powers Resolution: “The Cost is Human”
Position: Pelosi opposes President Trump's military actions in Iran without congressional authorization, arguing that the President has bypassed Congress and that American servicemembers are being killed and injured as a result.
Washington, D.C. – Today, ahead of the House vote on the Iran War Powers Resolution, Speaker Emerita Nancy Pelosi delivered remarks on the House Floor denouncing President Trump for bypassing Congress while American servicemembers lose their lives and hundreds more are injured.
Watch Pelosi's Floor remarks here.
Image
Source: open-data mirrors of the Senate eFD and House Clerk financial-disclosure systems. Disclosure within 30 days of trade is required by law (45 for spouse/dependent trades).
Top PAC donors · 2026 cycle
Political action committees that gave the most to this rep's principal campaign committee this cycle. PAC giving is direct organizational support — industry, ideological, or leadership.
No PAC contributions ranked for the 2026 cycle yet.
Source: OpenFEC (api.open.fec.gov) Schedule A receipts where contributor type is “committee.” Aggregated by contributing committee. Self-transfers from joint-fundraising / victory committees are excluded.
Top individual contributors · 2026 cycle
Itemized individual contributions over $200 to this rep's campaign committee, aggregated by donor employer. PAC giving is shown above; this section is people, not organizations.
1.STANFORD UNIVERSITY$7,700
2.HMI CAPITAL$7,000
3.TPG CAPITAL$7,000
4.KLEINER, PERKINS, CAUFIELD, & BYERS$7,000
5.GREYLOCK PARTNERS$7,000
6.UNIVERSITY OF CALIFORNIA, SAN FRANCISC$6,357
7.THE SCOTT FOUNDATION$5,000
8.RIVERVIEW CAPITAL INVESTMENTS$5,000
9.PARS EQUALITY CENTER$5,000
10.KEKER & VAN NEST LLP$5,000
Source: OpenFEC Schedule A receipts where contributor type is “individual,” aggregated by the donor's self-reported employer. This is a geographic / industry correlation, not a corporate endorsement.
